Literature DB >> 19665412

[Prevention of transfusion transmitted malaria in endemic area].

S Diop1, M Ndiaye, M Seck, B Chevalier, R Jambou, A Sarr, T N Dièye, A O Touré, D Thiam, L Diakhaté.   

Abstract

BACKGROUND: Malaria is a real public health problem in Africa; more than 300 million new cases and approximately two million deaths arise every year. In spite of the blood transfusion is a potential way of Plasmodium transmission, there is no consensus for measures to prevent post-transfusion malaria in endemic area. This work aimed at comparing some tools and to discuss various strategies to be implemented.
MATERIAL AND METHODS: The study concerned 3001 blood donors recruited in seven blood transfusion centers in Senegal during two periods: dry season (June-July, 2003) and rainy season (October-November, 2003). We evaluated the efficiency of the selection questionnaire for the blood donors to exclude those who are potentially asymptomatic carriers of the Plasmodium. Every donation was screened for pLDH antigen and antibodies against Plasmodium by Elisa technique (DiaMed, Cressier sur Morat, Suisse), morphological tests was also performed, as well as the screening of HIV, HBs Ag, HCV Ab and syphilis.
RESULTS: Median age of blood donors was of 27.7 years. Anti-Plasmodium antibodies prevalence was 65.3% and pLDH antigen was of 0.53%, all positivity was confirmed by microscopy. The prevalence of the other infectious markers was 11.7% for HBs Ag; 0.83% for syphilis; 0.49% for HCV Ab and 0.46% for HIV Ab. The risk factors associated with an asymptomatic carrier of Plasmodium were: the rainy season, irregular character of the blood donations, high frequency of malaria attacks in the past, and absence of treatment during the last episode.
CONCLUSION: Plasmodium represents the third risk of blood transmitted infectious agents after hepatitis B virus, syphilis, and before HCV and HIV in Senegal. The medical questionnaire is not useful enough for asymptomatic carriers deferral, and we propose to introduce Plasmodium screening. The screening for Plasmodium pLDH by Elisa technique seems to be the best tool in endemic area and the strategy of systematic screening is the most suited in terms of blood transfusion safety.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665412     DOI: 10.1016/j.tracli.2009.02.004

Source DB:  PubMed          Journal:  Transfus Clin Biol        ISSN: 1246-7820            Impact factor:   1.406


  16 in total

1.  Prevention and Care of Hepatitis B in Senegal; Awareness and Attitudes of Medical Practitioners.

Authors:  Antoine Jaquet; Gilles Wandeler; Judicaël Tine; Mouhamadou Baïla Diallo; Noel M Manga; Ndeye Mery Dia; Fatou Fall; François Dabis; Moussa Seydi
Journal:  Am J Trop Med Hyg       Date:  2017-08       Impact factor: 2.345

2.  Postrenal transplant Plasmodium vivax malaria: neglected and not benign.

Authors:  Vivek B Kute; Aruna V Vanikar; Pankaj R Shah; Jigar D Shrimali; Manoj R Gumber; Himanshu V Patel; Pranjal R Modi; Hargovind L Trivedi
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

3.  Effect of Asymptomatic Plasmodium falciparum Parasitaemia on Platelets Thrombogenicity in Blood Donors.

Authors:  Enoch Aninagyei; Patrick Adu; Tanko Rufai; Paulina Ampomah; Godwin Kwakye-Nuako; Alexander Egyir-Yawson; Desmond Omane Acheampong
Journal:  Indian J Hematol Blood Transfus       Date:  2021-01-02       Impact factor: 0.915

4.  Unusual transmission of Plasmodium falciparum, Bordeaux, France, 2009.

Authors:  Marc Olivier Vareil; Olivier Tandonnet; Audrey Chemoul; Hervé Bogreau; Melanie Saint-Léger; Maguy Micheau; Pascal Millet; Jean Louis Koeck; Alexandre Boyer; Christophe Rogier; Denis Malvy
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

5.  The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.

Authors:  Erhabor Osaro; Adias Teddy Charles
Journal:  J Blood Med       Date:  2011-02-06

6.  Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.

Authors:  Annie Leprêtre; Idrissa Ba; Karine Lacombe; Maryvonne Maynart; Abdalla Toufik; Ousseynou Ndiaye; Coumba Toure Kane; Joël Gozlan; Judicaël Tine; Ibrahim Ndoye; Gilles Raguin; Pierre-Marie Girard
Journal:  J Int AIDS Soc       Date:  2015-05-22       Impact factor: 5.396

7.  Real-time PCR diagnosis of Plasmodium vivax among blood donors.

Authors:  Sergio Batista-dos-Santos; Milene Raiol; Sidney Santos; Maristela G Cunha; Ândrea Ribeiro-dos-Santos
Journal:  Malar J       Date:  2012-10-12       Impact factor: 2.979

8.  Seroprevalence of malaria in blood donors and multi-transfused patients in Northern India: Relevance to prevention of transfusion-transmissible malaria.

Authors:  Anju Dubey; Priti Elhence; Ujjala Ghoshal; Anupam Verma
Journal:  Asian J Transfus Sci       Date:  2012-07

9.  Is a Plasmodium lactate dehydrogenase (pLDH) enzyme-linked immunosorbent (ELISA)-based assay a valid tool for detecting risky malaria blood donations in Africa?

Authors:  Pascal S Atchade; Cécile Doderer-Lang; Nicodème Chabi; Sylvie Perrotey; Tamer Abdelrahman; Casimir D Akpovi; Ludovic Anani; André Bigot; Ambaliou Sanni; Ermanno Candolfi
Journal:  Malar J       Date:  2013-08-08       Impact factor: 2.979

Review 10.  What is the best strategy for the prevention of transfusion-transmitted malaria in sub-Saharan African countries where malaria is endemic?

Authors:  Jobert Richie N Nansseu; Jean Jacques N Noubiap; Shalom Tchokfe Ndoula; Albert Frank M Zeh; Chavely Gwladys Monamele
Journal:  Malar J       Date:  2013-12-28       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.